On Wednesday, federal health agency has released initial results of a broad HIV clinical trial.
HIV stands for human immunodeficiency virus. The virus directly affects and kills cells of human immune system. It is mostly transmitted through sexual intercourse with an infected person. Some of the warning signs of HIV are skin rashes, bumps, nausea, vomiting, diarrhea, chronic fatigue and rapid weight loss.
HIV is quite different and complex from rest of the viruses. Once the deadly disease has infected the body, it cannot get rid of it.
The latest report of World Health Organization found that around 2.1 million people suffer from HIV every year.
Health experts from National Institutes of Health (NIH) carried out the study. More than 5,000 HIV patients from 35 different countries participated in the study.
The research revealed that early treatment and therapies decreases the risk of mortality in HIV patients. Patients who begin treatment early live longer and healthier life.
Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAD), commented on the outcome of the study. He states that findings can significantly cut the death rates in HIV patients.
Furthermore, researchers discovered that antiretroviral treatment (ART) radically reduces the risk of AIDS in HIV patents. It also averts the chances of serious health complications.